Distribution Solutions Group to Go Private in $1.6 Billion Deal at $35 Per Share
The $1.6 billion deal follows improved terms from the initial $29.50 offer.
NOTRELOAD AI
Abbott Raises 2026 Outlook After Solid Q2 Beat Driven by Diagnostics and Devices
Abbott delivered robust Q2 2026 earnings driven by 42% growth in its Diagnostics segment, led by strong Cologuard adoption.
GE Aerospace Soars on Services Strength, Raises Outlook Despite Margin Dip
Adjusted revenue up 24%, with significant increases in operating profit and free cash flow.
UnitedHealth Shares Surge as Q2 Results Top Forecasts and Guidance Raised
Strong cost control and Optum performance drive recovery.
Eli Lilly Enters Psychedelic Mental Health Space with $3.8 Billion AtaiBeckley Acquisition
Eli Lilly secures BPL-003 and other novel psychedelic-inspired treatments designed to provide rapid, long-lasting relief for treatment-resistant depression.
Eli Lilly in Advanced Talks to Acquire AtaiBeckley for Psychedelic Mental Health Portfolio
The deal would boost Lilly’s psychedelic pipeline for treatment-resistant depression.